Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

FIRSTBANK GUINEA EMERGES VICTORIOUS AT GLOBAL BRANDS MAGAZINE AWARDS

Published

on

firstbank-guinea-emerges-victorious-at-global-brands-magazine-awards

FirstBank Guinea receives prestigious ‘Best CSR Brand, Guinea‘, and ‘Best Mobile Banking Brand, Guinea‘ awards for 2023 at the distinguished Global Brand Awards.

LONDON, March 12, 2024 /PRNewswire/ — The Prestigious Global Brand Awards, an annual event by Global Brands Magazine (GBM) based in England, honours worldwide brands that distinguish themselves across diverse industries every year. GBM conducted a comprehensive assessment covering multiple criteria, including Corporate Social Responsibility, Mobile Banking Services, Brand Reputation and Recognition, Financial Performance, Innovation and Technology, among others. FirstBank Guinea demonstrated exceptional performance in this evaluation, highlighting its excellence and earning well-deserved recognition from Global Brands Magazine.

Commenting on winning the award, Jay Reddy, Director, Global Brands Magazine said, “FirstBank Guinea has demonstrated exceptional commitment to social responsibility and innovation in banking, and we are thrilled to recognize them as the recipients of the ‘Best CSR Brand, Guinea‘ and ‘Best Mobile Banking Brand, Guinea‘ awards at the prestigious Global Brand Awards 2023. Their dedication to making a positive impact in the community and providing cutting-edge mobile banking services sets a high standard for the industry. Congratulations to FirstBank Guinea on this well-deserved achievement.”

Commenting on winning the award, BAH Mamadou Macky, MD CEO, FirstBank Guinea said, “Firstbank Guinea is distinguished among her peers by several innovative products such as, Firstmonie, FirstMobile, USSD services amongst others. Besides the core commercial business, the Bank also distinguishes itself in other areas of responsibility within the operating environment, thus has earned the prestigious recognition as the bank with the Best Mobile App and the Best CSR Brand in Guinea in 2023. FirstBank Guinea  is  more than a bank, it’s a factory where we consistently think of our customer’s need and satisfactions.”

ABOUT FIRSTBANK GUINEA

FirstBank Guinea is a commercial bank and one of the commercial banking subsidiaries of FirstBank Nigeria. Formerly known as IC Bank (International Commerce Bank) which had been operating since 1997 in Guinea, FirstBank opened its doors in the country through the acquisition of ICB in 2013 and first commenced operations as FBNBank Guinea, before becoming officially pronounced FirstBank Guinea in July 2023, in alignment with our Group Head Office. With a history of 130years, the FirstBank Group with headquarters in Lagos, Nigeria, has an international presence through its FirstBank (UK) subsidiary in London, a representative office in Paris and another in China, with six subsidiaries in Africa located in Ghana, Sierra Leone, Gambia, DR Congo, Senegal and Guinea, through which it offers services and products to meet the financial needs of its clients”.

Firstbank Guinea, has been growing exponentially over its years of operation in the country, allowing it to rise to being one of the top ten banks in the country. We draw our strength from the experience of our group, the dynamism of our young and innovative staff, as well as deployment of the best technology in the market. In nine years of activity, Firstbank Guinea has opened nine branches across the country, with additional branches to be opened in 2024.

ABOUT GLOBAL BRANDS MAGAZINE (ENGLAND)

Global Brands Magazine (GBM) has been at the forefront, bringing news, views and opinions on brands shaping the future of their industry. The UK-based magazine provides its readers with the latest news and information on ‘best-in-class brands across the globe. Each year, GBM develops awards for companies that stand out, have a unique vision, exceptional service, innovative solutions and consumer-centric products among their industry leaders. The Magazine has over 10 million visitors and 14 million page views per month, making it one of the best online magazines. The Magazine also maintains a strong presence on social media, with over 20k+ Facebook likes, 10k+ Instagram followers, 25k+ Twitter followers, and 3k+ LinkedIn followers.

 ABOUT THE GLOBAL BRAND AWARDS

Global Brand Awards honours brands for their excellence in performance and rewards companies across different sectors for the quality of their services. The Brand Awards highlight the accomplishments of organisations that have performed remarkably well in finance, education, hospitality, automotive, lifestyle, education, real estate, technology, and others. Global Brand Awards recognise vital players who progress towards excellence by providing a platform to acknowledge their efforts. In addition, GBM strives to create awareness concerning the significance of such organisations and rewards them for their notable efforts with the ultimate global recognition. We are excited to announce the highly anticipated awards ceremony, which will take place at The Athenee Hotel in the heart of Bangkok, Thailand, in May 2024. To learn more about the awards, please visit the Brand Awards Winners section on the GBM website.

To nominate your company or business leader for the Global Brand Awards 2023, please click on the following link:

https://www.globalbrandsmagazine.com/nomination-form/

Check out our social media shout outs from the links below:

Facebook: https://bit.ly/49KhgAR
Linkedin: https://bit.ly/3v8DYDR
Twitter: https://bit.ly/3Pei2ho
Instagram: https://bit.ly/3Pf3a2d

Logo: https://mma.prnewswire.com/media/2311174/GBM_Awards_2023_Logo.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/firstbank-guinea-emerges-victorious-at-global-brands-magazine-awards-302086345.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Continue Reading

Trending